Feedback (LSE:FDBK) Land And Improvements : £0.00 Mil (As of Nov. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Feedback Land And Improvements?

Feedback's land and improvements for the quarter that ended in Nov. 2023 was £0.00 Mil.

Feedback Land And Improvements Historical Data

The historical data trend for Feedback's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback Land And Improvements Chart

Feedback Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Land And Improvements

Get a 7-Day Free Trial

Feedback Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Nov22	May23	Nov23
Land And Improvements	Get a 7-Day Free Trial															-	-	-	-	-

Feedback Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Feedback (LSE:FDBK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT

Website

https://www.fbkmed.com

Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines